Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
28.40    -1.00 (-3.40%)
Bid:
28.10
Ask:
28.30
Spread: 0.20 (0.712%)
Market Cap: £22.80m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Interim Management Statement

19 Nov 2009 07:00

RNS Number : 7208C
Headlam Group PLC
19 November 2009
 



19 November 2009

Interim Management Statement 

Headlam Group plc ("Headlam"), Europe's leading floorcoverings distributor, announces its Interim Management Statement for the period from 1 January 2009 to date.

Revenues for the ten months to 31 October

2009

£000

2008

£000

Change

UK

356,542

389,290

-8.4%

Continental Europe

85,963

81,207

+5.9%

Group

442,505

470,497

-5.9%

Total group revenue for the ten month period to 31 October reduced by 5.9%. UK like for like revenues reduced by 7.5% compared with the absolute reduction of 8.4% due to two less working days in 2009 compared with the same period in 2008. Revenues from our Continental European businesses declined by 10.0% on a like for like basis but currency effects and the contribution from Silvester, the Dutch residential business acquired in October 2008, lifted the overall performance to an increase of 5.9%.

Markets in the UK and Continental Europe remain challenging but trading in the UK, since June 2009, has shown an improving trend. Like for like revenues for the UK during the four month period to 31 October 2009 are down 3.0% compared with the previous period in 2008 with revenues for October 2009, showing positive like for like growth compared with October 2008. This compares with a like for like performance in the UK during the first six months of 2009, which showed a reduction of 10.7%. This improving trend is in part attributable to the softer 2008 second half comparatives but also, we believe, the contraction in market size, which appears to be slowing and perhaps beginning to stabilise at a new reduced base.

On the Continent, our business in France has seen a modest improvement over the last four months compared with the first six months of the year whereas our businesses in the Netherlands and Switzerland have experienced a continued contraction in trading. Excluding currency and acquisition affects, this has lead to like for like revenues for our Continental businesses decreasing by 10.5% during the last four months compared with a reduction of 9.7% during the first six months of 2009.

As described previously, the group's gross margin continues to be affected adversely by the change in product mix. Subject to any further changes in product mix and inflationary increases caused by currency and raw materials, we do not expect gross margins to change significantly over the medium term.

Outlook

Trading during November to date, in the UK, appears to be a continuance of the recent trend with revenue up by 0.5% compared with the comparable period last year and therefore, the board remains confident that their expectations for 2009 should be achieved.

Enquiries:

 

Headlam Group plc

Tony Brewer, Group Chief Executive  Tel: 01675 433000

Stephen Wilson, Group Finance Director

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEVLFFKFBZFBV
Date   Source Headline
3rd May 20227:00 amRNSTransaction in Own Shares
29th Apr 20223:46 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSTransaction in Own Shares
28th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTransaction in Own Shares
26th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
20th Apr 20227:00 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
14th Apr 20227:00 amRNSTransaction in Own Shares
12th Apr 20227:00 amRNSTransaction in Own Shares
8th Apr 20221:21 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSTransaction in Own Shares
5th Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 202210:30 amRNSReplacement: Transaction in Own Shares
4th Apr 20227:00 amRNSTransaction in Own Shares
1st Apr 202212:08 pmRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20229:57 amRNSTotal Voting Rights
31st Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:30 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20229:55 amRNSAnnual Report and Accounts and Notice of AGM
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20227:30 amRNSTransaction in Own Shares
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:02 amRNSShare Buyback Programme
9th Mar 20227:00 amRNSFinal Results
8th Mar 20227:00 amRNSBoard Changes
1st Mar 20223:49 pmRNSOption Exercise and Transfer of Treasury Shares
28th Feb 202210:41 amRNSTotal Voting Rights
16th Feb 20227:00 amRNSNotice of Final Results and Investor Presentation
14th Feb 20223:36 pmRNSOption Exercise and Transfer of Treasury Shares
1st Feb 20222:50 pmRNSOption Exercise and Transfer of Treasury Shares
31st Jan 20229:42 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSPre-Close Trading Update
19th Jan 20224:16 pmRNSOption Exercise and Transfer of Treasury Shares
4th Jan 20225:18 pmRNSExercise of share options / Transfer of shares
31st Dec 20217:00 amRNSTotal Voting Rights
22nd Dec 202112:33 pmRNSOption Exercise and Transfer of Treasury Shares
14th Dec 20217:00 amRNSAppointment of Joint Broker
7th Dec 20213:35 pmRNSOption Exercise and Transfer of Treasury Shares
30th Nov 202111:36 amRNSTotal Voting Rights
25th Nov 20217:00 amRNSESG and Trading Update
24th Nov 20213:45 pmRNSOption Exercise and Transfer of Treasury Shares
10th Nov 202111:31 amRNSOption Exercise and Transfer of Treasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.